Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
4.050
-0.200 (-4.71%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Zentalis Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -137.06 | -165.84 | -292.19 | -236.81 | -158.73 | |
| Depreciation & Amortization | 0.74 | 1.29 | 1.39 | 1.43 | 0.54 | |
| Loss (Gain) From Sale of Assets | -0.66 | -0.09 | 0.41 | 0.06 | -49.92 | |
| Asset Writedown & Restructuring Costs | 4.14 | 3.74 | 20 | - | 8.8 | |
| Loss (Gain) From Sale of Investments | -4 | -13.23 | -13.16 | -3.73 | 0.91 | |
| Loss (Gain) on Equity Investments | - | - | 16.01 | 16.28 | 1.83 | |
| Stock-Based Compensation | 20.72 | 67.27 | 54.82 | 46.84 | 35.74 | |
| Other Operating Activities | - | -47.45 | -0.97 | -1.08 | -9.88 | |
| Change in Accounts Receivable | 5 | -5 | - | - | - | |
| Change in Accounts Payable | -17.32 | -18.02 | 10.92 | 15.53 | 13.96 | |
| Change in Other Net Operating Assets | 3.19 | 6.48 | -5.06 | -2.28 | 2.64 | |
| Operating Cash Flow | -125.25 | -170.86 | -207.82 | -163.75 | -154.09 | |
| Capital Expenditures | - | -0.22 | -0.58 | -2.55 | -6.11 | |
| Sale of Property, Plant & Equipment | 0.7 | 0.07 | - | - | - | |
| Divestitures | - | - | - | - | -14.32 | |
| Investment in Securities | 130.93 | 176.72 | -43.88 | -111.63 | 2.31 | |
| Investing Cash Flow | 131.62 | 176.56 | -44.46 | -114.18 | -18.12 | |
| Issuance of Common Stock | 5.69 | 0.35 | 237.3 | 261.04 | 179.67 | |
| Repurchase of Common Stock | -9.98 | -0.24 | - | - | -1.15 | |
| Financing Cash Flow | -4.28 | 0.11 | 237.3 | 261.04 | 178.52 | |
| Net Cash Flow | 2.09 | 5.81 | -14.98 | -16.89 | 6.31 | |
| Free Cash Flow | -125.25 | -171.08 | -208.41 | -166.3 | -160.2 | |
| Free Cash Flow Margin | - | -253.74% | - | - | - | |
| Free Cash Flow Per Share | -1.74 | -2.41 | -3.19 | -3.15 | -3.75 | |
| Cash Income Tax Paid | 0.09 | 0.36 | 0.14 | 0.01 | 0.02 | |
| Levered Free Cash Flow | -75.87 | -67.1 | -86.97 | -88.02 | -89.16 | |
| Unlevered Free Cash Flow | -75.87 | -67.1 | -86.97 | -88.02 | -89.16 | |
| Change in Working Capital | -9.12 | -16.54 | 5.86 | 13.25 | 16.61 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.